背景:Kadsuracoccinea的果实(Lem。)A.C.史密斯是一种用于治疗月经异常的种族医学,更年期综合征,中国侗族女性不育。
目的:我们的研究目的是确定K.coccinea果实的挥发油谱并阐明其雌激素活性。
方法:果皮挥发油(PeO),纸浆挥发油(PuO),使用加氢蒸馏法提取K.coccinea的种子挥发油(SeO),并使用气相色谱-质谱(GC-MS)进行定性分析。使用细胞测定法在体外和使用未成熟雌性大鼠在体内评估雌激素活性。ELISA法检测血清17β-雌二醇(E2)和卵泡刺激素(FSH)水平。
结果:总计,46PeO,27普奥,和42个SeO成分,占89.96%,90.19%,和总成分的97%,分别,已确定。PeO中含量最高的化合物,普奥,SeO是β-石竹烯,γ-无定形,和正十六烷酸,分别。PeO诱导MCF-7细胞增殖,EC50为7.40μg/mL。10mg/kg的PeO皮下给药显着增加了未成熟雌性大鼠的子宫重量,对血清E2和FSH水平无影响。PeO充当ERα和ERβ的激动剂。PuO和SeO无雌激素活性。
结论:PeO的化学成分,普奥,和K.coccinea的SeO不同。PeO是雌激素活性的主要有效部分,为治疗更年期症状提供了植物雌激素的新来源。
BACKGROUND: The fruit of Kadsura coccinea (Lem.) A. C. Smith is an ethnomedicine used to treat abnormal menstruation, menopausal syndrome, and female infertility among the Dong Nationality in China.
OBJECTIVE: Our study aimed to identify the volatile oil profiles of the K. coccinea fruit and elucidate their estrogenic activity.
METHODS: The peel volatile oil (PeO), pulp volatile oil (PuO), and seed volatile oil (SeO) of K. coccinea were extracted using hydrodistillation and qualitatively analyzed using gas chromatography-mass spectrometry (GC-MS). Estrogenic activity was evaluated in vitro using cell assay and in vivo using immature female rats. Serum 17β-Estradiol (E2) and follicle-stimulating hormone (FSH) levels were detected using ELISA.
RESULTS: In total, 46 PeO, 27 PuO, and 42 SeO components representing 89.96%, 90.19%, and 97% of the total composition, respectively, were identified. The compounds with the highest content in PeO, PuO, and SeO were β-caryophyllene, γ-amorphene, and n-hexadecanoic acid, respectively. PeO induced proliferation of MCF-7 cells with an EC50 of 7.40 μg/mL. Subcutaneous administration of 10 mg/kg PeO significantly increased the weight of the uteri in immature female rats, with no effect on serum E2 and FSH levels. PeO acted as an agonist of ERα and ERβ. PuO and SeO showed no estrogenic activity.
CONCLUSIONS: The chemical compositions of PeO, PuO, and SeO of K. coccinea are different. PeO is the main effective fraction for estrogenic activities, providing a new source of phytoestrogen for the treatment of menopausal symptoms.